SCHEMBL9337028

SCHEMBL9337028

CCCCc1cccc(=O)n1Cc1ccc(C(=O)Nc2ccccc2C(=O)OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 3/20 0.49
PLK3 Q9H4B4 3/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C19 P33261 2/20 0.49
CYP2D6 P10635 1/20 0.49
TSHR P16473 1/20 0.49
APOBEC3A P31941 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
ABCG2 Q9UNQ0 1/20 0.46
HPGD P15428 3/20 0.45
AGTR1 P30556 1/20 0.45
MAPK10 P53779 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ELANE P08246 1/20 0.44
PRTN3 P24158 1/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9337724 0.90 PLK1 (0.62) PLK1PLK3AGTR1SMN1; SMN2NPC1
SCHEMBL9337467 0.86 IDH1 (0.45)
SCHEMBL9339133 0.83 TSHR (0.47) PLK1PLK3TSHRALDH1A1NPC1
SCHEMBL9533553 0.82 AGTR1 (0.55) AGTR1
SCHEMBL9339096 0.77 AGTR1 (0.54) APOBEC3AAPOBEC3GAGTR1SMN1; SMN2MAPT
SCHEMBL13719210 0.76 TSHR (0.72) CYP1A2CYP2C19CYP2D6TSHRAPOBEC3A
SCHEMBL9336977 0.75 ESR1 (0.42) AGTR1MAPK1HSD17B10KDM4EALDH1A1
SCHEMBL9340928 0.73 AGTR1 (0.43) AGTR1
SCHEMBL9339131 0.73
SCHEMBL9532259 0.72 AGTR1 (0.67) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5332750-A Treatment of hypertension, aldosteronism, cardiac insufficienc y MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1994-07-26 US disclosed
EP-0530702-A1 1,2-dihydro-2-oxopyridines as angiotensin II antagonists MERCK PATENT GmbH (DE) 1993-03-10 EP disclosed